ChinaAMC Fund reduces its holdings of 3SBIO (01530) by 1,594,500 shares, at a price of 30.55 Hong Kong dollars per share.
On November 12, Huatai Fund reduced its holdings of Sanesco Pharmaceutical (01530) by 1.5945 million shares, with a price of 30.55 Hong Kong dollars per share, for a total amount of approximately 487.12 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that, on November 12th, Invesco Fund reduced its holdings of 3SBIO (01530) by 1.5945 million shares, with a price of 30.55 Hong Kong dollars per share, totaling approximately 487.12 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 146 million shares, with a latest holding percentage of 5.99%.
Related Articles

MODERN INN DT (02322) plans to discount approximately 16.67% of the new shares with a maximum net raise of approximately HK$29.3 million.

Googol Technology (301510.SZ) shareholder Beijing Equity Investment Development Management Center plans to reduce its shareholding by no more than 0.7%

NEW FOCUS AUTO (00360) enters into a capital increase agreement with China Merchants Juxin.
MODERN INN DT (02322) plans to discount approximately 16.67% of the new shares with a maximum net raise of approximately HK$29.3 million.

Googol Technology (301510.SZ) shareholder Beijing Equity Investment Development Management Center plans to reduce its shareholding by no more than 0.7%

NEW FOCUS AUTO (00360) enters into a capital increase agreement with China Merchants Juxin.

RECOMMEND

Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025

Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025

On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025


